
Sampre Nutritions Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-04 10:10:34Sampre Nutritions Ltd experienced a pronounced decline on 4 Dec 2025, with the stock registering a 4.99% fall and exhibiting a rare scenario of exclusive selling interest. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within this FMCG sector player, marking a continuation of recent downward momentum.
Read More
Sampre Nutrition Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-12-03 11:08:25Sampre Nutrition, a microcap player in the FMCG sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of volatile stock returns and contrasting fundamental indicators, prompting investors to reassess the company’s position within the fast-moving consumer goods landscape.
Read More
Sampre Nutritions Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-03 09:41:03Sampre Nutritions Ltd experienced a pronounced decline on 3 Dec 2025, with the stock registering a sharp fall of 5.00% in a session dominated exclusively by sellers. This stark selling pressure contrasts markedly with the broader market, as the Sensex recorded a comparatively modest dip of 0.36% on the same day, signalling distress selling and a lack of buyer interest in the FMCG stock.
Read More
Sampre Nutritions Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
2025-12-02 15:30:36Sampre Nutritions has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention amid a backdrop of strong long-term performance.
Read More
Sampre Nutritions Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-02 11:40:39Sampre Nutritions Ltd experienced a pronounced decline on 2 Dec 2025, with the stock registering a 4.99% fall in a session dominated exclusively by sellers. This sharp drop comes amid a three-day losing streak, signalling heightened distress selling and a lack of buyer interest in the FMCG sector stock.
Read More
Sampre Nutritions Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-01 09:31:07Sampre Nutritions Ltd witnessed a sharp decline on 1 Dec 2025, marked by extreme selling pressure and an absence of buyers, resulting in a lower circuit scenario. The stock’s performance today starkly contrasts with the broader market, signalling distress selling and heightened investor caution.
Read MoreWhy is Sampre Nutrition falling/rising?
2025-11-29 01:01:02Recent Price Movement and Market Context Sampre Nutrition’s share price fell sharply by ₹1.7, underperforming its sector by over 5% on the day. The stock reached an intraday high of ₹34.85, marking a 2.5% increase from the previous close, but ultimately succumbed to selling pressure, hitting a low of ₹32.30. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling stronger selling interest as the session progressed. Despite this setback, the stock has delivered exceptional returns over the year, with a year-to-date gain of 102.83%, significantly outperforming the Sensex’s 9.68% rise. Over the past year, the stock has also appreciated by 63.77%, well above the benchmark’s 8.43%. However, the one-month performance tel...
Read More
Sampre Nutritions Faces Intense Selling Pressure Amid Lower Circuit
2025-11-28 09:50:44Sampre Nutritions Ltd experienced a pronounced decline on 28 Nov 2025, marked by exclusive selling interest and a lower circuit scenario. The stock recorded a 5.0% drop on the day, contrasting sharply with the Sensex’s modest 0.12% gain, signalling distress selling and a lack of buyer support in the FMCG sector.
Read More
Sampre Nutritions Surges to Upper Circuit Amidst Unprecedented Buying Interest
2025-11-25 15:30:30Sampre Nutritions witnessed extraordinary buying momentum today, hitting the upper circuit with a remarkable 4.9% gain. The stock’s performance stands in stark contrast to the broader market, reflecting a day dominated solely by buy orders and no sellers in the queue, signalling a potential multi-day circuit scenario.
Read MoreGeneral Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015
02-Feb-2026 | Source : BSEThe exchange is hereby informed that the companys Chairman and MD - Brahma Gurbani has been featured on the business magazine highlighting leadership and industry perspectives. This disclosure is made with the sole purpose of transparency to the stakeholders and corporate governance.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Jan-2026 | Source : BSEIntimation to the BSE under Regulation 74(5) of the SEBI DP Regulations 2018 with the certificate as received from the RTA for the third quarter ended 31 December 2025.
Board Meeting Outcome for Conversion Of FCCB And Allotment Of Equity Shares
22-Dec-2025 | Source : BSEConversion of 13 FCCBs to equity shares and allotment thereof.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Sampre Nutritions Ltd has announced 5:10 stock split, ex-date: 14 Nov 25
Sampre Nutritions Ltd has announced 1:1 bonus issue, ex-date: 14 Nov 25
No Rights history available